Li C, Moro S, Shostak K, O'Reilly FJ, Donzeau M, Graziadei A, McEwen AG, Desplancq D, Poussin-Courmontagne P, Bachelart T, Fiskin M, Berrodier N, Pichard S, Brillet K, Orfanoudakis G, Poterszman A, Torbeev V, Rappsilber J, Davey NE, Chariot A, Zanier K

Nat Commun. 2024 09 3;15(1):7692

Supramolecular Heterodimer Peptides Assembly for Nanoparticles Functionalization.

Mathieu C, Ghosh S, Draussin J, Gasser A, Jacquot G, Banerjee M, Gupta T, Schmutz M, Mirjolet C, Tillement O, Lux F, Klymchenko A, Donzeau M, Pivot X, Harlepp S, Detappe A

Adv Healthc Mater. 2024 03 5;:e2304250

Tracing endogenous proteins in living cells through electrotransfer of mRNA encoding chromobodies.

Juncker T, Richert L, Masson M, Zuber G, Chatton B, Donzeau M

Biotechnol J. 2024 02;19(2):e2300548

The Prodigious Potential of mRNA Electrotransfer as a Substitute to Conventional DNA-Based Transient Transfection.

Juncker T, Chatton B, Donzeau M

Cells. 2023 06 8;12(12):

Bioactivated and PEG-Protected Circa 2 nm Gold Nanoparticles for in Cell Labelling and Cryo-Electron Microscopy.

Groysbeck N, Hanss V, Donzeau M, Strub JM, Cianférani S, Spehner D, Bahri M, Ersen O, Eltsov M, Schultz P, Zuber G

Small Methods. 2023 04 10;:e2300098

Modular Site-Specific Conjugation of Nanobodies Using Two Co-Associating Tags.

Moeglin E, Barret L, Chatton B, Donzeau M

Int J Mol Sci. 2022 11 19;23(22):

Gold labelling of a green fluorescent protein (GFP)-tag inside cells using recombinant nanobodies conjugated to 2.4 nm thiolate-coated gold nanoparticles.

Groysbeck N, Donzeau M, Stoessel A, Haeberle AM, Ory S, Spehner D, Schultz P, Ersen O, Bahri M, Ihiawakrim D, Zuber G

Nanoscale Adv. 2021 12 7;3(24):6940-6948

Synthesis and biological evaluation of 2.4 nm thiolate-protected gold nanoparticles conjugated to Cetuximab for targeting glioblastoma cancer cells via the EGFR.

Groysbeck N, Stoessel A, Donzeau M, Cruz da Silva E, Lehmann M, Strub JM, Cianferani S, Dembélé K, Zuber G

Nanotechnology. 2019 Jan 16;:

A fast method for analyzing essential protein mutants in human cells.

Dietsch F, Donzeau M, Cordonnier AM, Weiss E, Chatton B, Vigneron M

BioTechniques. 2017 Feb;62(2):80-82

Dr DONZEAU Mariel

Fiche personne

coordonnées

Territoire

Statut

affiliation

équipes/plateformes

Projets

Cibler et tuer spécifiquement les cellules cancéreuses

Ingéniérie d'une immunotoxuine conditionnelle pour thérapie anticancéreuse

Ingénierie d'une immunotoxine conditonnelle pour la thérapie anticancéreuse

Publications

Molecular mechanism of IKK catalytic dimer docking to NF-κB substrates.